Krystal Biotech Inc (KRYS)

EBITDA Margin

49.94%

TTM · Period ending:

KRYS logo

KRYS EBITDA Margin

Latest reported49.94%
KRYS TTM EBITDA Margin (-5185.04% → 49.94%)
High-resolution chart · PNG

KRYS ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Krystal Biotech Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
49.9439%
48.0868%
46.9589%
51.7976%
50.1597%
46.4677%
40.3213%
32.7669%
75.0681%
72.9231%
54.3048%
-182.2698%
-4,003.5055%
-1,896.1778%
-916.6357%
-740.6923%
-714.05%
-776.943%
-1,780.6576%
-2,774%
-5,185.0394%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.